Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Puma Biotechnology (PBYI) Leases (2019 - 2025)

Puma Biotechnology's Leases history spans 7 years, with the latest figure at $5.4 million for Q4 2025.

  • For Q4 2025, Leases rose 17.34% year-over-year to $5.4 million; the TTM value through Dec 2025 reached $5.4 million, up 17.34%, while the annual FY2025 figure was $5.4 million, 17.34% up from the prior year.
  • Leases reached $5.4 million in Q4 2025 per PBYI's latest filing, down from $6.1 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $15.8 million in Q1 2021 to a low of $2.8 million in Q2 2025.
  • Average Leases over 5 years is $9.4 million, with a median of $9.2 million recorded in 2023.
  • The largest YoY upside for Leases was 17.34% in 2025 against a maximum downside of 54.61% in 2025.
  • A 5-year view of Leases shows it stood at $14.0 million in 2021, then fell by 18.94% to $11.4 million in 2022, then plummeted by 31.42% to $7.8 million in 2023, then crashed by 41.23% to $4.6 million in 2024, then grew by 17.34% to $5.4 million in 2025.
  • Per Business Quant, the three most recent readings for PBYI's Leases are $5.4 million (Q4 2025), $6.1 million (Q3 2025), and $2.8 million (Q2 2025).